BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 30149015)

  • 1. The deubiquitinase inhibitor b-AP15 induces strong proteotoxic stress and mitochondrial damage.
    Zhang X; Pellegrini P; Saei AA; Hillert EK; Mazurkiewicz M; Olofsson MH; Zubarev RA; D'Arcy P; Linder S
    Biochem Pharmacol; 2018 Oct; 156():291-301. PubMed ID: 30149015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted inhibition of the deubiquitinating enzymes, USP14 and UCHL5, induces proteotoxic stress and apoptosis in Waldenström macroglobulinaemia tumour cells.
    Chitta K; Paulus A; Akhtar S; Blake MK; Caulfield TR; Novak AJ; Ansell SM; Advani P; Ailawadhi S; Sher T; Linder S; Chanan-Khan A
    Br J Haematol; 2015 May; 169(3):377-90. PubMed ID: 25691154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of tumor cell apoptosis by a proteasome deubiquitinase inhibitor is associated with oxidative stress.
    Brnjic S; Mazurkiewicz M; Fryknäs M; Sun C; Zhang X; Larsson R; D'Arcy P; Linder S
    Antioxid Redox Signal; 2014 Dec; 21(17):2271-85. PubMed ID: 24011031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative Stress Induced by the Deubiquitinase Inhibitor b-AP15 Is Associated with Mitochondrial Impairment.
    Zhang X; Espinosa B; Saei AA; D'Arcy P; Zubarev RA; Linder S
    Oxid Med Cell Longev; 2019; 2019():1659468. PubMed ID: 31281566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 19S Deubiquitinase inhibitor b-AP15 is enriched in cells and elicits rapid commitment to cell death.
    Wang X; Stafford W; Mazurkiewicz M; Fryknäs M; Brjnic S; Zhang X; Gullbo J; Larsson R; Arnér ES; D'Arcy P; Linder S
    Mol Pharmacol; 2014 Jun; 85(6):932-45. PubMed ID: 24714215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of 19S proteasome deubiquitinating activity in Schistosoma mansoni affects viability, oviposition, and structural changes.
    do Patrocinio AB; Cabral FJ; Bitencourt ALB; Brigato OM; Magalhães LG; de Lima Paula LA; Franco L; Guerra-Sá And R; Rodrigues V
    Parasitol Res; 2020 Jul; 119(7):2159-2176. PubMed ID: 32424554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteasome inhibitor b-AP15 induces enhanced proteotoxicity by inhibiting cytoprotective aggresome formation.
    Hillert EK; Brnjic S; Zhang X; Mazurkiewicz M; Saei AA; Mofers A; Selvaraju K; Zubarev R; Linder S; D'Arcy P
    Cancer Lett; 2019 Apr; 448():70-83. PubMed ID: 30768956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance.
    Tian Z; D'Arcy P; Wang X; Ray A; Tai YT; Hu Y; Carrasco RD; Richardson P; Linder S; Chauhan D; Anderson KC
    Blood; 2014 Jan; 123(5):706-16. PubMed ID: 24319254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repurposing of auranofin: Thioredoxin reductase remains a primary target of the drug.
    Zhang X; Selvaraju K; Saei AA; D'Arcy P; Zubarev RA; Arnér ES; Linder S
    Biochimie; 2019 Jul; 162():46-54. PubMed ID: 30946948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteasomal cysteine deubiquitinase inhibitor b-AP15 suppresses migration and induces apoptosis in diffuse large B cell lymphoma.
    Jiang L; Sun Y; Wang J; He Q; Chen X; Lan X; Chen J; Dou QP; Shi X; Liu J
    J Exp Clin Cancer Res; 2019 Nov; 38(1):453. PubMed ID: 31694672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proapoptotic effects of the novel proteasome inhibitor b-AP15 on multiple myeloma cells and natural killer cells.
    Feng X; Holmlund T; Zheng C; Fadeel B
    Exp Hematol; 2014 Mar; 42(3):172-82. PubMed ID: 24291587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The proteasome deubiquitinase inhibitor b-AP15 enhances DR5 activation-induced apoptosis through stabilizing DR5.
    Oh YT; Deng L; Deng J; Sun SY
    Sci Rep; 2017 Aug; 7(1):8027. PubMed ID: 28808321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel inhibitor of proteasome deubiquitinating activity renders tumor cells sensitive to TRAIL-mediated apoptosis by natural killer cells and T cells.
    Sarhan D; Wennerberg E; D'Arcy P; Gurajada D; Linder S; Lundqvist A
    Cancer Immunol Immunother; 2013 Aug; 62(8):1359-68. PubMed ID: 23689729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting proteasomal deubiquitinases USP14 and UCHL5 with b-AP15 reduces 5-fluorouracil resistance in colorectal cancer cells.
    Ding W; Wang JX; Wu JZ; Liu AC; Jiang LL; Zhang HC; Meng Y; Liu BY; Peng GJ; Lou EZ; Mao Q; Zhou H; Tang DL; Chen X; Liu JB; Shi XP
    Acta Pharmacol Sin; 2023 Dec; 44(12):2537-2548. PubMed ID: 37528233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of b-AP15 on the 20S proteasome.
    Huang L; Jung K; Chen CH
    Biomolecules; 2014 Oct; 4(4):931-9. PubMed ID: 25317846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel deubiquitinase inhibitor b-AP15 triggers apoptosis in both androgen receptor-dependent and -independent prostate cancers.
    Cai J; Xia X; Liao Y; Liu N; Guo Z; Chen J; Yang L; Long H; Yang Q; Zhang X; Xiao L; Wang X; Huang H; Liu J
    Oncotarget; 2017 Sep; 8(38):63232-63246. PubMed ID: 28968984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of proteasome deubiquitinating activity as a new cancer therapy.
    D'Arcy P; Brnjic S; Olofsson MH; Fryknäs M; Lindsten K; De Cesare M; Perego P; Sadeghi B; Hassan M; Larsson R; Linder S
    Nat Med; 2011 Nov; 17(12):1636-40. PubMed ID: 22057347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deubiquitinase inhibitor b-AP15 activates endoplasmic reticulum (ER) stress and inhibits Wnt/Notch1 signaling pathway leading to the reduction of cell survival in hepatocellular carcinoma cells.
    Ding Y; Chen X; Wang B; Yu B; Ge J
    Eur J Pharmacol; 2018 Apr; 825():10-18. PubMed ID: 29454609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of apoptosis via proteasome inhibition in leukemia/lymphoma cells by two potent piperidones.
    Contreras L; Calderon RI; Varela-Ramirez A; Zhang HY; Quan Y; Das U; Dimmock JR; Skouta R; Aguilera RJ
    Cell Oncol (Dordr); 2018 Dec; 41(6):623-636. PubMed ID: 30088262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of determinants for in vitro resistance to the small molecule deubiquitinase inhibitor b-AP15.
    Mofers A; Perego P; Selvaraju K; Gatti L; Gullbo J; Linder S; D'Arcy P
    PLoS One; 2019; 14(10):e0223807. PubMed ID: 31639138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.